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Summary The relationship between colony numbers and concentration of cells plated is an important
parameter of clonogenic assay systems. The cloning efficiency for an ideal sample should be independent of
cell concentration, thus giving a straight line through the origin when colony numbers are plotted against cell
concentration. A simple statistical method has been developed to test if this is the case for individual tumour
samples. Colony data from 51 freshly obtained tumour samples, which had sufficient cells to plate 3 or more
dilutions and gave at least 20 colonies per plate at one or more of the dilutions, were tested. The results
indicated that colony formation was linear for 27 (53%) of the samples. The remaining 24 samples could be
classified into 2 groups: type I, in which cloning efficiencies increased with increasing cell concentration and
type II, which had reduced cloning efficiencies at high cell concentrations. Fifteen (29%) of the samples had
type I non-linearity and 9 (18%) exhibited non-linearity of type II. These findings indicate that the
relationship between colonies and cells plated should be examined for each biopsy sample particularly in each
experiment where the effects ofcytotoxic drugs are tested.
Assays in vitro for human tumour progenitor cells
have received a great deal of attention in the past
few years because of their potential use for
predictive testing of chemotherapeutic agents on
individual tumours (Salmon et al., 1978). The major
premise behind these tests is that tumour cells
which form colonies in semi-solid media are those
most likely to be responsible for growth of the
tumor in vivo. Thus, drugs that reduce the numbers
of colonies in vitro should be effective for treating
that tumour in the clinic. In fact, a number of
studies appear to show reasonably good correlations
between in vitro assay results and clinical responses
(reviewed by Salmon, 1984). Unfortunately, technical
and theoretical problems limit the general
applicability of such systems (Selby et al., 1983).
One fundamental aspect of any clonogenic assay,
which is important if drug assay results are to be
interpreted in terms of progenitor cell kill, is the
relationship between numbers of cells plated and
colony numbers. The protocols used in most
laboratories are based on the original method of
Salmon et al. (1978) where a single concentration of
cells is plated for untreated controls as well as for
the drug-treated groups. Therefore, it must be
assumed that the cloning efficiency is independent
of the cell concentration seeded, if inhibition of
colony formation is to be a direct measure of
progenitor cell reduction. Recently, Meyskens et al.
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(1983) have shown that this assumption is not valid
for a number of human tumour cell lines and
melanoma biopsies where cloning efficiencies were
decreased at high cell concentrations.
We have examined the relationship between cell
concentration and colony numbers with freshly
obtained tumour material from a variety of tumour
types. In addition, a theoretical basis for testing the
linearity of these relationships has been developed.
Materials and methods
Sample handling and culture
Tumour material was obtained from patients
treated at the Hopital Cantonal Universitaire in
Geneva and at several hospitals in the Lausanne
area. Solid tumour samples were cut into small
pieces shortly after surgery and were placed in
medium for transport. This medium (EF+) consists
of a 1:1 mixture of EMED, an enriched Dulbecco's
modified Eagle's medium, and FMED, a modified
Ham's F-12 nutrient mixture (Eliason, 1984; Eliason
et al., 1984) which is further supplemented with
1 mgml1- bovine serum albumin (Cohn fraction V,
Fluka, Buchs, Switzerland). The albumin was
dextran-charcoal treated and deionized as described
by Iscove et al. (1980). All media contained peni-
cillin (100,000ul-1) and streptomycin (100mg -1).
Malignant effusions were collected in sterile con-
tainers with 10uml- of preservative-free heparin
(Hoffmann-La Roche, Basel, Switzerland).
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Solid tumour samples were cut into smaller
pieces and incubated with collagenase (Sigma, St.
Louis MD) and DNase (Sigma) as described by
Slocum et al. (1981). After incubation, the samples
were filtered through 200pm mesh screens to
remove large pieces and were centrifuged. The cells
were washed 2 or 3 times with EF+. Liquid
effusions were centrifuged and the cells were
washed twice with EF+. Samples with high
numbers of erythrocytes were resuspended in
0.17MNH4Cl and kept at 4°C for 10min. Cell
debris was removed by centrifugation through a
layer of foetal calf serum (FCS; KC Biologicals,
Kansas City, MO) followed by Ficoll-hypaque
(Pharmacia, Uppsala, Sweden) separation. Samples
with low percentages of viable cells (<40%) were
also separated on Ficoll-hypaque.
After washing, cells were resuspended in EF+
and drawn through needles of decreasing diameter.
Viable cells were counted on a haemocytometer
after dilution in a solution of Trypan blue. If
necessary, the cell suspension was left for 10min at
room temperature to allow larger aggregates to
sediment. The top one-half to two-thirds of the
medium was then removed and the viable cell
concentration was determined.
The methylcellulose clonal assay system has been
described in detail previously (Eliason et al., 1984).
Briefly, it consists of a 1:1 mixture of EMED and
FMED supplemented with 0.9% methylcellulose
(4000mPa.s; Fluka), 5% FCS, 1% bovine serum
albumin, nucleosides and deoxynucleosides,
204mg 1- fresh L-glutamine, 20pM ethanolaime,
trace elements, 80pgml-1 human transferrin,
3pgml-1 insulin, 2.8pgml-' linoleic acid and
2.6pgml-1 cholesterol. The medium for some
samples contained 10-6M hydrocortisone sodium
succinate in addition. Cells were plated at three or
four different concentrations: either at 10 ml-',
7.5 x104 mIl-' and 5 x 104ml-P1 or at 105mI-1,
6.7 x 104ml-1, 3.3 x 104 and 104ml-1. Duplicate or
triplicate 1 ml aliquoies of each cell concentration
were plated in bacterial Petri dishes (Greiner,
Niirtingen, FRG; No. 627102).
Plates were examined after 1 day of incubation
using an inverted microscope. Cell aggregates with
diameters .60,pm were counted. Thereafter, plates
were examined, at which time they were fed with
0.5ml fresh medium. Final colony counts were
made after 3 weeks of incubation. Assuming the
results of Meyskens et al. (1984) are applicable to
our culture system, the cut off of 60pm for colony
size implies a minimum average of 3 cell divisions
in a colony
Theoretical considerations
An ideal clonogenic assay for progenitor cells
should give a direct estimate of relative numbers of
progenitors in each cell suspension tested. There are
two constraints for this to be the case: (i) the
probability (p) that any colony forming cell (CFC)
will proliferate must be independent of cell concen-
tration and (ii) no colonies should be present in
plates with no cells. It follows that the general
equation for such a relationship is:
Y=p (number of CFC),
where Y is the number of colonies.
Since, in practice, the number of CFC in the cell
suspension to be assayed is unknown, this
relationship can be rewritten as
Y=p*(CFC frequency) *X,
where X is the number of cells plated or the cell
concentration when all cultures are of equal
volume. The frequency of CFC is the number of
CFC divided by X. If p and the frequency of CFC
are constant, as they should be for an ideal cell
suspension, then these two terms can be combined
to give
Y=bX, (1)
with b being equal to the cloning efficiency. By
analogy with the terminology used for haemopoietic
clonal assays, b can also be referred to as the
frequency of colony forming units-tumour (CFU-
Tu). The exact relationship between CFUs and
CFCs will be defined by p.
It is clear that b will be a measure of CFC
frequency, provided that the culture conditions are
the same for all plates so that p remains constant.
On the other hand, if a single cell suspension is
used to test different culture conditions, then
changes in b will reflect changes in p.
Colony formation by progenitor cells in equal
volume cultures can be considered as a random
sampling problem and therefore, the numbers of
colonies counted in replicate plates can be assumed
to fit a Poisson distribution. The mean value of the
colony counts (Yi) for each cell concentration (Xi)
is an estimate of the mean of the Poisson
distribution for that concentration. The variance is
also estimated by Yi and for high values of Yi, the
standard deviation is approximated by (Yi)112. Since
the Poisson distribution is asymmetric, it is
probably best to use 95% confidence limits obtained
from compiled Tables (see for example, Diem &
Lentner, 1970), at least for low values of Yi.
The assumption that colony counts fit a Poisson
distribution means that the variance of Y will
increase as X increases. Thus, the best fit estimate
(Armitage, 1971) for b in equation (1) can beNON-LINEARITY OF CLONOGENIC ASSAYS 313
calculated by
ZEXi
Statistical analysis
To determine if the frequency of CFU-Tu in
tumour samples was, in fact, independent of cell
concentration, the value b was calculated from
equation (2) for each set of data. Fit of the actual
data to the hypothetical lines was examined by the
chi-squared test
EXi(Yi/Xi-b)2 (3)
b( b)
with k-I degrees of freedom, k being the number
of cell concentrations tested. Since most tumour
samples have cloning efficiencies (b) < 1%, the term
(1-b) in the denominator will be 1. Equation (3),
therefore, can be simplified to give:
2 (Yi-bXi)2
bXi
A practical limitation of this test is that there
should be 20 or more colonies with at least one cell
dilution. For chi-squared probabilities >0.05, the
CFU-Tu frequencies were considered to be
independent of cell concentration and equal to b,
therefore giving a linear relationship between
colony numbers and cell concentration in the form
of equation (1).
The data were also transformed to give a
logarithmic-logarithic (ln-ln) relationship. Standard
least-squares regression analysis was used to
calculate a regression line in the form
ln Y=ln c+m(lnX). (5)
Equation is equivalent to Y=cX', where the
number of colonies is proportional to the cell
concentration raised to the power m. When m=1,
this reduces to equation (1) with c=b.
Results
The method we have developed for testing the
linearity of colony formation with numbers of cells
seeded is highly dependent on the assumption that
colony numbers in replicate plates fit a Poisson
distribution. There is experimental evidence for this
assumption for in vivo (Hendry, 1973) and in vitro
(van den Engh, 1976) colony formation by haemo-
poietic progenitor cells. However, it was important
to verify this for the human tumour cell system. We
routinely monitor our technique by plating cells
from the WiDr colon adenocarcinoma cell line at 4
cell concentrations with 6 replicates each. The
results from one such experiment are shown in
Table I. Fit of the replicate counts to a Poisson
distribution can be estimated by the chi-squared
Poisson heterogeneity test. Of 20 groups from 5
experiments by experienced workers, only 1 group
has been significantly different (P<0.05) from a
Poisson distribution.
To provide evidence that this assumption holds
true for tumour biopsy samples, we have compared
the means and variances calculated from the sum of
squares about the mean for all dilutions of the 51
samples described in Tables II-V. If the results fit a
Poisson distribution, then half the variances should
be greater than the mean and half less. Of 186 such
comparisons, 94 variances were less than their
respective means, 8 were equal to the mean, and 84
greater. Therefore, the assumption of Poisson
distributions appears justified.
Colony counts from 51 consecutive human
tumour samples having sufficient cells to plate at 3
or more cell concentrations and giving 20 or more
colonies per plate with at least one dilution were
analysed by the chi-squared test described in
Materials and methods. The results of the analyses
are summarized for 22 ovarian carcinoma samples
TABLE I Fit of colony numbers obtained with a human tumour cell line (WiDr) to
a Poisson distribution
Cell Concentration Mean number Normal
cellsml1 n ofcolonies variance x2 p
1,000 6 476 963 10.2a 0.1 P0.05
300 6 154 195 6.33 0.3 P0.25
100 6 56 28 2.46 0.8 P0.7
30 6 17 26 7.53 0.2P0.1
aCalculated from x2= Y314 J.F. ELIASON et al.
Table II Relationships between cell and colony numbers:
Ovarian carcinoma
Cloning
efficiencies (b)a
Sample colonies 10' cells P(x2)b Type
1 123 <0.005 I
2 50 NSC Linear
3 50 <0.010 I
4 59 <0.005 I
5 32 <0.005 I
6 25 NS Linear
7 36 NS Linear
8 28 NS Linear
9 331 NS Linear
10 101 NS Linear
11 95 <0.005 I
12 22 NS Linear
13 142 <0.005 II
14 592 <0.005 II
15 205 NS Linear
16 58 NS Linear
17 109 <0.01 I
18 30 <0.005 II
19 41 NS Linear
20 62 <0.005 I
21 440 <0.025 I
22 34 NS Linear
aCalculated from equation (2), Materials and methods.
bFrom equation (4), Materials and methods. cNot
significant (P<0.05).
Table Ill Relationship between cell and colony numbers:
Breast carcinoma
Cloning
efficiencies (b)
Sample colonies 10-' cells P(X2) Type
1 92 <0.005 II
2 152 NS Linear
3 54 NS Linear
4 88 <0.005 II
5 62 NS Linear
6 16 <0.025 I
7 200 NS Linear
8 22 <0.01 I
9 18 NS Linear
See Table II for explanations.
in Table II, for 9 breast carcinoma samples in Table
III, and for 9 colo-rectal carcinoma samples in
Table IV and 11 miscellaneous tumour samples (4
non-small cell lung, 1 small cell lung, 2 osteo-
sarcomas, 2 kidney, 1 melanoma, and 1 carcinoma
of unknown origin) in Table V.
Table IV Relationships between cell and colony numbers:
Colo-rectal tumours
Cloning
efficiencies (b)
Sample colonies 10' cells P(X2) Type
1 38 NS Linear
2 184 <0.005 II
3 41 NS II
4 131 NS Linear
5 46 NS Linear
6 87 NS Linear
7 45 <0.005 I
8 172 <0.005 I
9 42 <0.005 II
See Table II for explanations.
For 27 (53%) of the samples, colony formation
appeared to be independent of cell concentration,
(P<0.05), thus fitting a straight line through the
origin. The colony data for two such samples are
shown in figure 1. Inspection of the curves for the
remaining 20 samples, which had chi-squared P-
values ofless than 0.05, indicated that they could be
further classified into two types: (i) those with
cloning efficiencies that increased with increasing
cell concentration (type I non-linearity) and (ii)
those with decreased cloning efficiencies at the
highest cell concentration (type II non-linearity).
Fifteen (29%) of the samples in our series fit into
the first category and 9 (18%) fit into the second
category.
Results from two representative samples with
non-linear relationships of type I are shown in
Figure 2. With all 11 samples of this type, it was
observed that the average colony size was also
increased with increasing cell concentration.
Examination of the data for samples with type II
relationships indicated that they might be either
'linear' (Figure 3A) or having increasing cloning
efficiencies (Figure 3B) at the lower cell con-
centrations. In some, but not all, samples of this
type, it could be seen that the size of colonies was
smaller at the highest cell concentration. However,
in such cases, there was always a high 'background'
of small clusters (<60Mm) and single cells.
Taken by tissue origin of the tumours, non-
linearity was seen with 11/22 ovarian samples, with
8 examples of type I and 3 of type II. Four of nine
breast samples exhibited non-linearity with 2
examples each of type I and type II. The same
results were obtained with colo-rectal samples. The
remaining samples showing non-linear relationships
were 3/5 lung tumours, 1/1 melanoma and 1/2
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Table V Relationship between cell and colony numbers: Miscellaneous tumours
Cloning
efficiencies (b)
Sample/tumour type Colonies 10-' cells P(x2) Type
1 Lung: non small cell 33 NS Linear
2 Lung: non small cell 61 <0.050 I
3 Lung: non small cell 46 NS Linear
4 Lung: non small cell 40 <0.025 II
5 Lung: small cell 27 <0.005 II
6 Osteosarcoma 16 <0.025 I
7 Osteosarcoma 44 NS Linear
8 Kidney 70 NS Linear
9 Kidney 1,240 NS Linear
10 Unknown 62 NS Linear
11 Melanoma 17 <0.005 I
See Table II for explanations.
100 -
80
60
40
20
00
100.
80
60
40
20
a
200
160
120
80
a) 4-
._
m
C
0
Z-
40
0
a
b
100 -
80 -
60 -
40 -
20
Cells/plate ( x 104)
Figure 1 Two examples of linear relationships
between colony numbers and numbers of cells plated:
(a) ovarian carcinoma (Table II, sample 2) and (b)
carcinoma of the kidney (Table V, sample 8). The
open circles represent the mean numbers of colonies at
each cell dilution and the vertical lines represent 95%
confidence limits, assuming a Poisson distribution. The
solid lines represent the best-fit lines through the
origins.
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Figure 2 Two examples of non-linear relationships
between colony numbers and numbers of cells plated
having increasing cloning efficiencies (type I): (a)
ovarian carcinoma (Table II, sample) and (b) ovarian
carcinoma (Table II, sample 3). See legend to Figure 1
for explanation of symbols.
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Table VI Calculated cell kill and colony inhibition values
at 70% levels for ovarian carcinoma samples with ln-ln
slopes >1
% Cell kill with % Colony reduction
70% reduction in representing
Samplea m coloniesc 70% kill ofcellsd
1 2.07b 44 92
2 1.49 56 83
3 1.79 49 88
4 3.19 32 98
5 3.18 32 98
6 2.10 44 92
8 1.35 59 80
11 1.70 51 87
12 1.89 47 90
17, 20 1.20 63 76
18 1.99 45 91
21 1.25 62 78
aFrom Table II. bFrom equation (5) Materials and
methods. 'Calculated by [1-0.3)1/M] x 100. dCalculated by
[I1-(0.3) ] x 100.
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Figure 3 Two examples of non-linear relationships
between colony numbers and numbers of cells plated
with decreased cloning efficiency at highest cell
concentration (type II): (a) colon carcinoma (Table IV,
sample 2) and (b) small carcinoma of the lung (Table
V, sample 5). For explanation of symbols, see legend
to Figure 1.
Discussion
A direct relationship between numbers of
clonogenic cells plated and colonies counted is an
important requirement for clonogenic assay systems.
We have described a simple statistical method for
testing whether colony formation is independent of
cell concentration. Since the assumption that colony
counts fit a Poisson distribution is crucial for this
test, it was necessary to examine the dispersion of
counts in replicate plates before it could be applied.
Analysis of the results from 51 human tumour
biopsy samples plated in our semi-solid culture
system indicated that colony numbers are not linear
with numbers of cells seeded for a significant
proportion of samples. While the statistical test
showed that some results did not fit the ideal
relationship, actual inspection of the data suggested
that two types of non-linearity were involved.
Our findings confirm and extend those of
Meyskens et al. (1983), who have described in detail
one type of non-linearity, that which we have
termed type II, where cloning efficiencies are
decreased at higher cell concentrations. One
explanation for such behaviour by tumour cells
(particularly cell lines and melanoma biopsy
samples with high cloning efficiencies) is that the
culture systems may be able to support only a
limited volume of tumour growth (Thomson et al.,
1984). This mechanism is probably not a major
factor in the cases of type II non-linearity reported
here, since cultures were fed each week with fresh
medium and relatively few colonies were evident at
any cell dilution with many of the samples. In such
cases, production of inhibitory factors by tumour
cells, or by normal inflammatory cells plated
together with tumour cells (Buick et al., 1980;
Hamburger et al., 1983) may be involved.
Cloning efficiencies for about one-third of the
samples examined appeared to increase with higher
cell concentrations (type I). Curves of type I can be
described by equations where cell concentrations is
raised to a power greater than unity. Such
relationships have the implication that more than
one cell is required to give rise to one colony, thus
supporting the use of the term colony forming unit
(CFU) for human tumour colony assays. The size of
the unit would be defined by the exponent of the
relationship (slope, m, of the ln-ln transformed
regression curve). In theory, if m=2, then two cells
would be needed for formation of one colony. The
cells involved might be two clonogenic cells or one
clonogenic cell and one accessory cell such as a
macrophage or lymphocyte (Hamburger et al.,
1983).
Cooperation between interacting cells could be
modulated by cell-to-cell contact or by release of
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factor(s) into the medium. The latter possibility is
supported by the finding that conditioned media
from breast cancer cell lines will increase the
cloning efficiencies of cells from freshly obtained
breast tumour samples (Hug et al., 1984). It is
attractive to speculate that samples with type I
relationships have enhanced colony formation at
high cell densities due to autocrine production of
growth factors, possibly through activation of
oncogenes (Waterfield et al., 1983; Doolittle et al.,
1983). However, addition of non-specific nutrient
factors to suboptimal media have been shown to
affect the apparent linearity of colony formation by
cells from human tumour cell lines (Eliason et al.,
1984).
The two types of non-linearity have opposite
consequences for chemosensitivity tests. As
indicated by Meyskens et al. (1983) type II
relationships can lead to predictions of drug
resistance when, in fact, CFUs have been killed.
This would provide an explanation for the false
negatives (resistance to a drug in vitro with
sensitivity of the tumour in the clinic) reported for
-10% of the cases in studies correlating in vitro
assay results with clinical findings.
An even more important aspect with respect to
the predictive potential of these assays is the rate of
false positive results (i.e., sensitivity in vitro but
resistance in vivo). They constitute nearly 30% of all
predicted sensitivities (Salmon, 1984). Non-linear
relationships of type I could provide an explanation
for false positives since a moderate cell kill by a
drug would result in a much larger reduction in
colony numbers. Curves of this type can be fitted
using a ln-ln transformation as described by
equation (5). It must be pointed out that the values
for m calculated by standard regression analysis are
only a rough approximation because the variances
are not equal. More accurate estimates can be
obtained by using weighted values for the regression
to equalize the variances. In Table VI the ln-ln
regression equations for each ovarian sample from
Table II with m greater than one have been used to
calculate the reduction in cells when colony
numbers are reduced by 70% (Salmon et al., 1981)
and conversely the reduction in colony numbers
that represents a cell kill equal to 70%. Obviously,
calculations of this type could be of potential
benefit for improving the predictive accuracy of
clonogenic assays. Since the logarithmic trans-
formation can be applied to linear relationships
as well as type I non-linearity, this approach could
be used with about 80% of the samples in our series.
It may be argued that the high incidence of non-
linearity we have observed is inherent to our
culture system, which employs a single layer of
methylcellulose rather than a double layer of agar
and contains a relatively low concentration of
serum (5%). However, reported non-linearity of
colony formation in a more conventional double
layer agar system (Meyskens et al., 1983) suggests it
to be a more universal phenomenon and a property
of the samples themselves.
In light of the cellular heterogeneity of tumour
samples, both in terms of biological characteris-
tics of the tumour cells and with respect to the
content of other non-malignant cells, it would be
advisable to include as internal controls plates with
appropriate cell dilutions for every sample cultured.
Detailed knowledge of the relationship between
numbers of colonies and cells seeded in each assay
could provide a means for correcting poten-
tial artifacts in chemosensitivity tests. Furthermore,
the Poisson distribution of progenitor cells in
replicate plates has important consequences for
statistical treatment ofresults from clonogenic assays.
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